blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2125026

EP2125026 - BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.07.2015
Database last updated on 20.09.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, HU, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
AllAccem, Inc.
1300 Industrial Road, Suite 16
San Carlos, CA 94070 / US
[2013/52]
Former [2009/49]For all designated states
Allaccem, Inc.
Menlo Business Park 1455 Adams Drive, Suite 1180
Menlo Park, California 94025 / US
Inventor(s)01 / WHITEFORD, Jeffery A.
1300 Industrial Road, Suite 16
San Carlos, California 94070 / US
 [2013/49]
Former [2009/49]01 / WHITEFORD, Jeffery A.
1908 Valdez Avenue
Belmont, California 94002 / US
Representative(s)Dossmann, Gérard
Casalonga & Partners
Bayerstrasse 71-73
80335 München / DE
[2014/39]
Former [2009/49]Dossmann, Gérard
Bureau D.A. Casalonga & Josse Bayerstrasse 71/73
80335 München / DE
Application number, filing date08730417.621.02.2008
[2009/49]
WO2008US54611
Priority number, dateUS20070902577P21.02.2007         Original published format: US 902577 P
US20070964312P10.08.2007         Original published format: US 964312 P
US20070965154P17.08.2007         Original published format: US 965154 P
US2008002933216.02.2008         Original published format: US 29332
[2009/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008103847
Date:28.08.2008
Language:EN
[2008/35]
Type: A2 Application without search report 
No.:EP2125026
Date:02.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 28.08.2008 takes the place of the publication of the European patent application.
[2009/49]
Type: B1 Patent specification 
No.:EP2125026
Date:24.09.2014
Language:EN
[2014/39]
Search report(s)International search report - published on:EP20.11.2008
ClassificationIPC:A61K47/48
[2009/49]
CPC:
B82Y5/00 (EP,US); A61K47/6949 (EP,US); A61K47/547 (EP,US);
A61P1/02 (EP); A61P13/12 (EP); A61P27/16 (EP);
A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP);
A61P35/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/49]
Extension statesALNot yet paid
BANot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:AUF VERBRÜCKTER POLYCYCLISCHER VERBINDUNG BASIERENDE ZUSAMMENSETZUNGEN ZUR HEMMUNG UND LINDERUNG VON ERKRANKUNGEN[2009/49]
English:BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE[2009/49]
French:COMPOSITIONS À BASE DE COMPOSÉS POLYCYCLIQUES PONTÉS POUR L'INHIBITION ET LE TRAITEMENT DE MALADIES[2009/49]
Entry into regional phase21.09.2009National basic fee paid 
21.09.2009Designation fee(s) paid 
21.09.2009Examination fee paid 
Examination procedure21.09.2009Examination requested  [2009/49]
02.11.2009Amendment by applicant (claims and/or description)
05.08.2010Despatch of a communication from the examining division (Time limit: M06)
10.02.2011Reply to a communication from the examining division
17.10.2012Despatch of a communication from the examining division (Time limit: M06)
02.04.2013Reply to a communication from the examining division
18.09.2013Communication of intention to grant the patent
10.01.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.02.2014Despatch of a communication from the examining division (Time limit: M02)
11.02.2014Reply to a communication from the examining division
14.04.2014Communication of intention to grant the patent
13.08.2014Fee for grant paid
13.08.2014Fee for publishing/printing paid
13.08.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.08.2010
Opposition(s)25.06.2015No opposition filed within time limit [2015/36]
Fees paidRenewal fee
26.02.2010Renewal fee patent year 03
25.02.2011Renewal fee patent year 04
27.02.2012Renewal fee patent year 05
26.02.2013Renewal fee patent year 06
24.02.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.02.2008
BG24.09.2014
CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
MC24.09.2014
MT24.09.2014
PL24.09.2014
RO24.09.2014
SI24.09.2014
SK24.09.2014
TR24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
LU21.02.2015
[2017/39]
Former [2017/03]CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
MC24.09.2014
MT24.09.2014
PL24.09.2014
RO24.09.2014
SI24.09.2014
SK24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
LU21.02.2015
Former [2016/12]CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
MC24.09.2014
PL24.09.2014
RO24.09.2014
SI24.09.2014
SK24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
LU21.02.2015
Former [2015/46]CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
MC24.09.2014
PL24.09.2014
RO24.09.2014
SK24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
LU21.02.2015
Former [2015/44]CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
PL24.09.2014
RO24.09.2014
SK24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
LU21.02.2015
Former [2015/24]CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
PL24.09.2014
RO24.09.2014
SK24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
Former [2015/23]CY24.09.2014
EE24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
RO24.09.2014
SK24.09.2014
GR25.12.2014
IS24.01.2015
PT26.01.2015
Former [2015/22]CY24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
RO24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/12]CY24.09.2014
HR24.09.2014
LT24.09.2014
LV24.09.2014
GR25.12.2014
Former [2015/11]CY24.09.2014
LT24.09.2014
GR25.12.2014
Former [2015/08]LT24.09.2014
Cited inInternational search[PXL]WO2007070801  (ALLACCEM INC [US], et al) [PXL] 1-24,29-104 * the whole document *;
 [PX]US2007202342  (WHITEFORD JEFFERY A [US], et al) [PX] 1-24,29-104 * the whole document *;
 [A]  - ZHUANG X-M ET AL, "Cyanide and imidazolate bridged macrocyclic dinuclear CuII complexes: Synthesis, structure and magnetic properties", INORGANICA CHIMICA ACTA, X, XX, (20050330), vol. 358, no. 6, ISSN 0020-1693, pages 2129 - 2134, XP004777639 [A] 1 * Scheme 1 *

DOI:   http://dx.doi.org/10.1016/j.ica.2004.12.044
 [A]  - PIERRE J L ET AL, "SYNTHESIS OF A NOVEL MACROBICYCLIC CAVITY POSSESSING SIX CONVERGENT HYDROXYL GROUPS AND ACTING AS A SIDEROPHORE", ANGEWANDTE CHEMIE INTERNATIONAL EDITION IN ENGLISH, (1991), vol. 30, no. 1, ISSN 0570-0833, pages 85 - 86, XP002497022 [A] 1-104

DOI:   http://dx.doi.org/10.1002/anie.199100851
 [A]  - SHIN C -G ET AL, "Novel synthesis of the main central 2,3,6-trisubstituted pyridine skeleton [Fragment A-B-C] of a macrobicyclic antibiotic, cyclothiazomycin", BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 200207 JP, (200207), vol. 75, no. 7, ISSN 0009-2673, pages 1583 - 1596, XP002497023 [A] 1-104

DOI:   http://dx.doi.org/10.1246/bcsj.75.1583
by applicantGB599722
 US2455807
 US3066112
 US3179623
 US3194784
 US3751399
 US3926906
 US4544359
 US4547531
 US4666896
 US5145853
 US5276068
 US5348988
 US5393516
 US5496545
 US5534565
 US5597560
 US5667775
 US5753268
 US5753269
 US5948390
 US5990110
 US2001009931
 US6326417
 US6440405
 US6500004
 US6562329
 US6593395
 US2003134933
 US6756364
 US2004267009
 US6858203
 US6908609
 US2005158252
 US2005252413
    - ZHUANG, X.-M. ET AL., "Cyanide and imidazolate bridged macrocyclic dinuclear Cull complexes: Synthesis, structure and magnetic properties", INORGANICA CHIMICA ACTA, (2005), vol. 358, pages 2129 - 2134
    - PIERRE, J. L. ET AL., "Synthesis of a Novel Macrobicyclic Cavity Possessing Six Convergent Hydroxyl Groups and Acting as a Siderophore", ANGEW. CHEM. INT. ED. ENGL., (1991), vol. 30, no. 1, doi:doi:10.1002/anie.199100851, pages 85 - 86, XP002497022

DOI:   http://dx.doi.org/10.1002/anie.199100851
    - DENG-JYE YANG; LUCY SUN HWANG, JOURNAL OF CHROMATOGRAPHY A, (2006), vol. 1119, pages 277 - 284
    - MARCIL, V., J. NUTR., (2003), vol. 133, pages 2180 - 2183
    - HUSSAIN, M. M., JOURNAL OF LIPID RESEARCH, (2003), vol. 44, pages 22 - 32
    - PERNAK ET AL., "Synthesis and anti-microbial activities of some pyridinium salts with alkoxymethyl hydrophobic group", EUR. J. MED. CHEM., (2001), vol. 36, doi:doi:10.1016/S0223-5234(01)80005-2, pages 899 - 907, XP004400910

DOI:   http://dx.doi.org/10.1016/S0223-5234(01)80005-2
    - T. LOFTSSON, J. MED. CHEM., (2003), vol. 46, pages 4173 - 4181
    - S.L. COOPER, "Recent Advances in Antimicrobial Dendrimers", ADV. MATER., (2000), vol. 12, no. 11, doi:doi:10.1002/(SICI)1521-4095(200006)12:11<843::AID-ADMA843>3.0.CO;2-T, pages 843 - 846, XP000963567

DOI:   http://dx.doi.org/10.1002/(SICI)1521-4095(200006)12:11<843::AID-ADMA843>3.0.CO;2-T
    - S.L. COOPER, BIOMACROMOLECULES, (2000), vol. 1, no. 3, pages 473 - 480
    - A.M. KLIBANOV, BIOTECHNOLOGY LETTERS, (2003), vol. 25, pages 1661 - 1665
    - CHAND ET AL., "Synthesis of a Heteroditopic Cryptand Capable of Imposing a Distorted Coordination Geometry onto Cu(II): Crystal Structures of the Cryptand (L), [Cu(L)(CN)](picrate), and [Cu(L)(NCS)] {picrate) and Spectroscopic Studies of the Cu(II) Complexes", INORG CHEM, (1996), vol. 35, pages 3380 - 3387
    - "27 and 28", BERTRAM G. KATZUNG,, REMINGTON'S PHARMACEUTICAL SCIENCES, 8th Edition, MACK PUBLISHING COMPANY, (1990), vol. 28, pages 484 - 528
    - J.M SLACK, J. DENT. RES, (1971), vol. 50, no. 1, pages 78 - 82
    - J. CHEM. SOC., (1946), pages 729 - 737
    - J. CHEM. SOC, (1948), pages 1630 - 1636
 US20060638327
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.